# Privia Health Reports Third Quarter 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/PRVA/privia-health-reports-third-quarter-2025-financial-results
Ticker: PRVA
Company: Privia Health
Source: Privia Health
Published: 2025-11-06 11:00 EST
Original Source URL: https://ir.priviahealth.com
## Summary

Very Strong Third Quarter and Year-to-Date Performance Across the Business Net Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q’24 Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q’24 FY’25 Guidance Raised Above High End for All Key Operating and Financial Metrics

## Article Body
Very Strong Third Quarter and Year-to-Date Performance Across the Business Net Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q’24 Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q’24 FY’25 Guidance Raised Above High End for All Key Operating and Financial Metrics
## Recent Company News
- 2026-05-27 13:00 EST — [Privia Health Enters New Jersey](https://biopharmsignal.com/news/PRVA/privia-health-enters-new-jersey) — Source: Privia Health
- 2026-05-07 10:00 EST — [Privia Health Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PRVA/privia-health-reports-first-quarter-2026-financial-results) — Source: Privia Health
- 2026-04-08 13:00 EST — [Privia Health to Report First Quarter 2026 Results on Thursday, May 7](https://biopharmsignal.com/news/PRVA/privia-health-to-report-first-quarter-2026-results-on-thursday-may-7) — Source: Privia Health
- 2026-03-24 13:00 EST — [Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence](https://biopharmsignal.com/news/PRVA/privia-health-earns-2026-hfma-map-award-for-revenue-cycle-excellence) — Source: Privia Health
- 2026-02-26 11:00 EST — [Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results](https://biopharmsignal.com/news/PRVA/privia-health-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Privia Health
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)